Visibly

VDAP is an online vision test that received FDA clearance in 2022, making it the first tool of its kind that optometrists can use to remotely generate or renew a glasses prescription. The clearance creates a regulatory safe harbor that optical retailers, telehealth apps, and insurers can license, allowing them to offer at-home prescription renewal without building their own regulated diagnostic.

Visibly's strategy is to be the infrastructure behind other brands, not a consumer-facing marketplace. Its website describes tailored solutions, branded test experiences, and custom email workflows integrated into a client's own offering. No standalone consumer app or retail storefront is promoted as its primary go-to-market motion.

Federal FDA clearance preempts many state-level restrictions that previously blocked online refraction providers. Visibly couples this clearance with a nationwide network of licensed eye-care providers and automated prescription-verification APIs, which together aim to satisfy both the FDA's requirements and the Federal Trade Commission's Contact Lens Rule mandates.

The platform includes four modules: an at-home or in-office vision test; asynchronous and live video visits with eye-care providers for non-emergency concerns; automated prescription verification that streamlines compliance with the Contact Lens Rule; and fulfillment automation via pre-built integrations with leading eyewear labs and distributors.

Visibly's website pitches 'leading companies' in optical and retail — optical chains, contact-lens e-commerce sites, employers offering vision benefits, and health plans that want to add vision services to a member portal. The company frames itself as a platform for any organization that wants to dispense prescriptions, measure visual acuity, or automate contact-lens fulfillment.